<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-associated trypsin inhibitor TATI is expressed together with trypsin in many <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> forms, and an elevated serum level associates with poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>TATI can reduce tissue destruction by inhibiting trypsin and other proteinases, and in some <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> forms, its high tissue expression is associated with favourable prognosis </plain></SENT>
<SENT sid="2" pm="."><plain>We analyzed the prognostic values of TATI, trypsinogen-1 and trypsinogen-2 immunoexpression from tissue array blocks constructed from surgical specimens of 592 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: TATI positivity correlated negatively with differentiation (p &lt; 0.001) and positively with the histological type of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (p &lt; 0.001) </plain></SENT>
<SENT sid="4" pm="."><plain>Trypsinogen-1 and trypsinogen-2 positivity correlated with Dukes' stage (p = 0.045, p = 0.050); the percentage of trypsinogen-1- and trypsinogen-2-positive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> was lower in metastasized (Dukes' stage C-D) than in local (Dukes' stage A-B) disease </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, trypsinogen-2 correlated inversely with differentiation (p = 0.012) </plain></SENT>
<SENT sid="6" pm="."><plain>In univariate analysis, the expression of TATI associated with more favourable <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific survival (p = 0.010) </plain></SENT>
<SENT sid="7" pm="."><plain>In multivariate analysis, low TATI (p = 0.044), age (p &lt; 0.001), Dukes' stage (p &lt; 0.001), <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> differentiation (p = 0.020) and location in the rectum (p = 0.006) were independent prognostic factors for adverse outcome </plain></SENT>
<SENT sid="8" pm="."><plain>Furthermore, TATI expression was an independent prognostic factor in a subgroup of trypsinogen-1- (p = 0.007) and trypsinogen-2-positive (p = 0.006) <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: TATI tissue expression is an independent prognostic marker in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>